Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06328634
Other study ID # LOCAL/2014/FV-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2008
Est. completion date December 31, 2012

Study information

Verified date March 2024
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

OBJECTIVES: We aimed to study the characteristics of patients presenting with a Bacillus cereus infection in a university hospital. METHODS: We performed a retrospective analysis of the clinical, biological, and treatment-related data of patients hospitalized in our university hospital between January 1st, 2008 and December 31st, 2012 and diagnosed with a B. cereus infection. We identified a subgroup of patients presenting with bacteremia and looked for risk factors for death within that group of patients.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 31, 2012
Est. primary completion date December 31, 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients diagnosed with a B. cereus infection - patients adult (>18) Exclusion Criteria: - patientn diagnosed without infection by B. Cereus

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

References & Publications (1)

Veysseyre F, Fourcade C, Lavigne JP, Sotto A. Bacillus cereus infection: 57 case patients and a literature review. Med Mal Infect. 2015 Nov-Dec;45(11-12):436-40. doi: 10.1016/j.medmal.2015.09.011. Epub 2015 Oct 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary descriptive analysis of patients' characteristics and B. cereus infection or colonization. 4 years
See also
  Status Clinical Trial Phase
Completed NCT03377530 - Contamination of Bacillus Species Sepsis.